Themis Medicare Limited
NSE:THEMISMED.NS
263.95 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,817.608 | 3,543.233 | 3,946.141 | 2,306.698 | 2,015.883 | 1,837.547 | 2,095.033 | 2,458.015 | 2,327.974 | 2,018.815 | 1,950.66 | 1,734.963 | 1,576.397 | 2,502.784 | 2,283.608 | 2,145.341 | 2,386.104 | 1,775.98 |
Cost of Revenue
| 2,313.704 | 1,183.649 | 1,519.946 | 805.33 | 648.706 | 695.231 | 730.055 | 830.136 | 873.519 | 923.51 | 862.369 | 816.565 | 1,461.563 | 2,274.69 | 1,964.09 | 2,079.087 | 2,072.96 | 1,530.736 |
Gross Profit
| 1,503.904 | 2,359.584 | 2,426.195 | 1,501.368 | 1,367.177 | 1,142.316 | 1,364.978 | 1,627.879 | 1,454.455 | 1,095.305 | 1,088.291 | 918.398 | 114.834 | 228.094 | 319.518 | 66.254 | 313.144 | 245.244 |
Gross Profit Ratio
| 0.394 | 0.666 | 0.615 | 0.651 | 0.678 | 0.622 | 0.652 | 0.662 | 0.625 | 0.543 | 0.558 | 0.529 | 0.073 | 0.091 | 0.14 | 0.031 | 0.131 | 0.138 |
Reseach & Development Expenses
| 136.871 | 142.544 | 136.375 | 84.967 | 34.321 | 45.846 | 52.835 | 51.38 | 35.053 | 26.637 | 16.602 | 20.204 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 108.979 | 93.445 | 99.221 | 66.853 | 44.584 | 61.865 | 62.245 | 59.813 | 40.186 | 329.209 | 23.873 | 27.909 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 223.59 | 170.302 | 260.776 | 149.21 | 81.364 | 132.151 | 145.172 | 111.06 | 150.518 | 31.783 | 100.576 | 76.463 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 1,111.315 | 263.747 | 359.997 | 216.063 | 125.948 | 194.016 | 207.417 | 170.873 | 190.704 | 360.992 | 525.806 | 455.082 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| 47.555 | 115.048 | 12.646 | 6.815 | 29.113 | 1.173 | 8.858 | 6.054 | 8.971 | 114.56 | 31.186 | 20.496 | 288.927 | 1.972 | 28.828 | 7.45 | 20.235 | 31.515 |
Operating Expenses
| 1,111.315 | 1,790.023 | 1,564.643 | 1,091.9 | 1,092.619 | 1,199.308 | 1,186.779 | 1,259.614 | 1,087.658 | 1,016.548 | 939.099 | 839.937 | 288.927 | 1.972 | 28.828 | 7.45 | 20.235 | 31.515 |
Operating Income
| 392.589 | 820.793 | 861.552 | 409.468 | 274.558 | -56.992 | 178.199 | 368.265 | 366.797 | 78.757 | 149.192 | 78.461 | -174.093 | 226.122 | 290.69 | 58.804 | 292.909 | 213.729 |
Operating Income Ratio
| 0.103 | 0.232 | 0.218 | 0.178 | 0.136 | -0.031 | 0.085 | 0.15 | 0.158 | 0.039 | 0.076 | 0.045 | -0.11 | 0.09 | 0.127 | 0.027 | 0.123 | 0.12 |
Total Other Income Expenses Net
| -46.211 | -95.644 | 91.068 | 3.839 | -5.812 | -68.98 | -64.839 | -173.06 | -171.566 | -18.723 | -112.616 | -119.079 | -158.7 | -103.073 | -83.705 | -152.697 | -94.689 | -79.483 |
Income Before Tax
| 346.378 | 725.149 | 952.62 | 413.307 | 268.746 | -125.972 | 113.36 | 195.205 | 195.231 | 60.034 | 36.576 | -40.618 | -332.793 | 123.049 | 206.985 | -93.893 | 198.22 | 134.246 |
Income Before Tax Ratio
| 0.091 | 0.205 | 0.241 | 0.179 | 0.133 | -0.069 | 0.054 | 0.079 | 0.084 | 0.03 | 0.019 | -0.023 | -0.211 | 0.049 | 0.091 | -0.044 | 0.083 | 0.076 |
Income Tax Expense
| 99.197 | 156.141 | 223.813 | 56.278 | 20.93 | -18.374 | 1.018 | 6.801 | 12.582 | 17.714 | 13.118 | 7.106 | 5.059 | 20.743 | 0.558 | 17.543 | 16.427 | 26.62 |
Net Income
| 435.238 | 569.01 | 728.808 | 357.03 | 247.817 | -107.416 | 112.971 | 194.899 | 193.229 | 50.063 | 23.458 | -47.724 | -337.852 | 99.835 | 205.857 | -113.551 | 180.152 | 106.589 |
Net Income Ratio
| 0.114 | 0.161 | 0.185 | 0.155 | 0.123 | -0.058 | 0.054 | 0.079 | 0.083 | 0.025 | 0.012 | -0.028 | -0.214 | 0.04 | 0.09 | -0.053 | 0.076 | 0.06 |
EPS
| 4.73 | 6.18 | 7.92 | 3.89 | 2.7 | -1.17 | 12.28 | 17.66 | 19.12 | 7.34 | 3.19 | -5.93 | -41.97 | 14.16 | 25.57 | -14.1 | 22.38 | 13.24 |
EPS Diluted
| 4.72 | 6.17 | 7.91 | 3.88 | 2.7 | -1.17 | 12.28 | 17.66 | 18.96 | 7.24 | 3.05 | -5.93 | -41.97 | 14.16 | 25.57 | -14.1 | 22.38 | 13.24 |
EBITDA
| 515.052 | 925.741 | 1,112.448 | 608.247 | 462.897 | 58.118 | 292.609 | 388.426 | 414.408 | 301.565 | 242.748 | 164.629 | -96.148 | 304.67 | 368.167 | 137.446 | 356.714 | 265.128 |
EBITDA Ratio
| 0.135 | 0.261 | 0.282 | 0.264 | 0.23 | 0.032 | 0.14 | 0.158 | 0.178 | 0.149 | 0.124 | 0.095 | -0.061 | 0.122 | 0.161 | 0.064 | 0.149 | 0.149 |